CADTH | Evidence Driven
CADTH | Evidence Driven

Subcutaneous Immunoglobulin Therapy for Neurological and Autoimmune Conditions

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1195-000

Question

1. What is the clinical effectiveness of subcutaneous immunoglobulin therapy in patients with neurologic and/or autoimmune conditions?

Key Message

No evidence was found regarding the clinical effectiveness of subcutaneous immunoglobulin therapy in patients with neurologic and/or autoimmune conditions.

Files

Subcutaneous Immunoglobulin Therapy for Neurological and Autoimmune Conditions View PDF
Last Updated : October 21, 2021